Skip to main content
Fig. 1 | Journal of Hematology & Oncology

Fig. 1

From: Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket study

Fig. 1

Waterfall plots of tumor response A spider plots B and Kaplan–Meier curves of progression-free C and overall survival D Only patients with available tumor assessments after central review at data cutoff are shown. Changes in tumor size were centrally assessed by blinded independent review according to Response Evaluation Criteria in Solid Tumors (RECIST) 1.1. Maximum change in sum of diameters from baseline is shown on the waterfall plots (A); time on treatment is shown on spider plots (B)

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us